Prevalence of Depression and Anxiety among Women with Polycystic Ovary Syndrome and their Association with Hormonal and Metabolic Parameters
DOI:
https://doi.org/10.53350/pjmhs20231710394Keywords:
PCOS; Depression; Anxiety; Insulin resistance.Abstract
Background: Polycystic ovary syndrome (PCOS) remains one of the most common endocrine disorders in women of reproductive age. PCOS encompasses a variety of symptoms across multiple domains, including frank reproductive, metabolic, and psychological disturbances. Numerous studies suggest a greater occurrence of depression and anxiety in women with PCOS, which may be a result of the endocrine perturbations, insulin resistance, dysregulated body fat, and metabolic syndrome. These comorbidities affect the women's quality of life and likely hinder their overall health and well-being. Moreover, psychological comorbidities in women with PCOS affect treatment compliance and health outcomes over an extended period.
Objectives: To ascertain the levels of incidence of depression and anxiety in women suffering from PCOS and the relationship of these conditions with certain hormonal and metabolic variables.
Methodology: This cross-sectional study examined women aged 18–45 years diagnosed with PCOS and seen in a tertiary gynecology clinic. Using standard tools, depression and anxiety were measured. Participants had their anthropometric measures taken, and a blood draw was done to test for hormonal levels (total testosterone, luteinizing hormone, follicle-stimulating hormone) and for metabolic variables (fasting glucose, fasting insulin, HOMA-IR, lipid profile). The information was analyzed in SPSS, with statistical significance accepted if p was < 0.05.
Results: A total of 130 women with PCOS were included, with a mean age of 26.8 ± 5.4 years. Depression was observed in 38.5% of participants, while anxiety was present in 42.3%. Women with depression demonstrated significantly higher body mass index and HOMA-IR values compared to those without depression (p=0.01). Anxiety showed a significant association with elevated total testosterone levels and dyslipidemia (p=0.02). Increasing insulin resistance and hyperandrogenism were significantly correlated with higher depression and anxiety scores.
Conclusion: Evidence suggests that women who have PCOS are at higher risk of having depression and anxiety. This is often linked to factors such as depression, adverse metabolic factors, and insulin resistance. Screening for mental health and psychological comorbidities as part of the metabolic and endocrine workup in women with PCOS is vital to provide complete care.
References
Al Wattar BH, Teede H, Garad R, Franks S, Balen A, Bhide P, et al. Harmonising research outcomes for polycystic ovary syndrome: an international multi-stakeholder core outcome set. Human reproduction (Oxford, England). 2020;35(2):404-12.
Alesi S, Ee C, Moran LJ, Rao V, Mousa A. Nutritional Supplements and Complementary Therapies in Polycystic Ovary Syndrome. Advances in nutrition (Bethesda, Md). 2022;13(4):1243-66.
Alur-Gupta S, Lee I, Chemerinski A, Liu C, Lipson J, Allison K, et al. Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome. F&S reports. 2021;2(2):230-7.
Cantelmi T, Lambiase E, Unfer VR, Gambioli R, Unfer V. Inositol treatment for psychological symptoms in Polycystic Ovary Syndrome women. European review for medical and pharmacological sciences. 2021;25(5):2383-9.
Chaudhari NK, Nampoothiri LP. Neurotransmitter alteration in a testosterone propionate-induced polycystic ovarian syndrome rat model. Hormone molecular biology and clinical investigation. 2017;29(2):71-7.
Cooney LG, Dokras A. Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment. Current psychiatry reports. 2017;19(11):83.
Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction (Oxford, England). 2017;32(5):1075-91.
Cui P, Ma T, Tamadon A, Han S, Li B, Chen Z, et al. Hypothalamic DNA methylation in rats with dihydrotestosterone-induced polycystic ovary syndrome: effects of low-frequency electro-acupuncture. Experimental physiology. 2018;103(12):1618-32.
Ee C, Smith CA, Costello M, Moran L, Steiner GZ, Stepto N, et al. Acupuncture or auricular electro-acupuncture as adjuncts to lifestyle interventions for weight management in PCOS: protocol for a randomised controlled feasibility study. Pilot and feasibility studies. 2020;6:53.
Erensoy H, Niafar M, Ghafarzadeh S, Aghamohammadzadeh N, Nader ND. A pilot trial of metformin for insulin resistance and mood disturbances in adolescent and adult women with polycystic ovary syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2019;35(1):72-5.
Ethirajulu A, Alkasabera A, Onyali CB, Anim-Koranteng C, Shah HE, Bhawnani N, et al. Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome. Cureus. 2021;13(9):e18013.
Fernandez RC, Moore VM, Van Ryswyk EM, Varcoe TJ, Rodgers RJ, March WA, et al. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies. Nature and science of sleep. 2018;10:45-64.
He FF, Li YM. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. Journal of ovarian research. 2020;13(1):73.
Ilie IR. Neurotransmitter, neuropeptide and gut peptide profile in PCOS-pathways contributing to the pathophysiology, food intake and psychiatric manifestations of PCOS. Advances in clinical chemistry. 2020;96:85-135.
Lin H, Liu M, Zhong D, Ng EHY, Liu J, Li J, et al. The Prevalence and Factors Associated With Anxiety-Like and Depression-Like Behaviors in Women With Polycystic Ovary Syndrome. Frontiers in psychiatry. 2021;12:709674.
Lua ACY, How CH, King TFJ. Managing polycystic ovary syndrome in primary care. Singapore medical journal. 2018;59(11):567-71.
Özdemir O, Kurdoglu Z, Yıldız S, Özdemir PG, Yilmaz E. The relationship between atypical depression and insülin resistance in patients with polycystic ovary syndrome and major depression. Psychiatry research. 2017;258:171-6.
Patil AD, Vaidya RA, Begum S, Chauhan SL, Mukherjee S, Kokate PP, et al. An integrated multidisciplinary model of care for addressing comorbidities beyond reproductive health among women with polycystic ovary syndrome in India. The Indian journal of medical research. 2022;156(3):449-58.
Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, Głowińska A, Spaczyński R, Rybakowski F, et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatria polska. 2019;53(4):955-66.
Wang C, Wu W, Yang H, Ye Z, Zhao Y, Liu J, et al. Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges. Trends in genetics : TIG. 2022;38(5):468-82.
Wang D, He B. Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. Diabetes, metabolic syndrome and obesity : targets and therapy. 2022;15:1281-91.
Wang Y, Ni Z, Li K. The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 2021;37(12):1072-8.
Zhou X, Jaswa E, Pasch L, Shinkai K, Cedars MI, Huddleston HG. Association of obstructive sleep apnea risk with depression and anxiety symptoms in women with polycystic ovary syndrome. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2021;17(10):2041-7.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2023 Muhammad Muslim Khan, Fatima, Naila, Izaz Jamal, Ijaz Gul, Pirzada Muneeb
This work is licensed under a Creative Commons Attribution 4.0 International License.
